ALTIMMUNE, INC. Earnings Per Share (Basic)
ALTIMMUNE, INC. (ALT) reported Earnings Per Share (Basic) of -$0.12 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- ALTIMMUNE, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.12.
- ALTIMMUNE, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.18.
- ALTIMMUNE, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.21.
- ALTIMMUNE, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.27.
- ALTIMMUNE, INC. earnings per share, basic for fiscal 2025 was -$1.00.
- ALTIMMUNE, INC. earnings per share, basic for fiscal 2024 was -$1.34.
- ALTIMMUNE, INC. earnings per share, basic for fiscal 2023 was -$1.66.
- ALTIMMUNE, INC. earnings per share, basic for fiscal 2022 was -$1.81.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.12 10-Q · filed 2026-08-12 | -$0.29 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | -$0.18 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | -$1.00 10-K · filed 2026-03-06 | |||
| 2025-09-30 | -$0.21 10-Q · filed 2025-11-06 | -$0.74 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | -$0.27 10-Q · filed 2026-08-12 | -$0.53 10-Q · filed 2026-08-12 | ||
| 2025-03-31 | -$0.26 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | -$1.34 10-K · filed 2026-03-06 | |||
| 2024-09-30 | -$0.32 10-Q · filed 2025-11-06 | -$1.01 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | -$0.35 10-Q · filed 2025-08-12 | -$0.69 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | -$0.34 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | -$1.66 10-K · filed 2025-02-27 | |||
| 2023-09-30 | -$0.39 10-Q · filed 2024-11-12 | -$1.10 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | -$0.32 10-Q · filed 2024-08-08 | -$0.72 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | -$0.40 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$1.81 10-K · filed 2024-03-27 | |||
| 2022-09-30 | -$0.48 10-Q · filed 2023-11-07 | -$1.37 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | -$0.42 10-Q · filed 2023-08-10 | -$0.90 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | -$0.44 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | -$2.35 10-K · filed 2023-02-28 | |||
| 2021-09-30 | -$0.81 10-Q · filed 2022-11-10 | -$1.79 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$0.60 10-Q · filed 2022-08-11 | -$0.99 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | -$0.38 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | -$1.91 10-K · filed 2022-03-15 | |||
| 2020-09-30 | -$0.54 10-Q · filed 2021-11-09 | -$1.74 10-Q · filed 2021-11-09 | ||
| 2016-12-31 | $1.16 10-K · filed 2017-03-14 | -$0.12 derived: net income ÷ weighted average shares · filed 2018-04-02 | -$0.15 derived: net income ÷ weighted average shares · filed 2018-04-02 | $2.97 10-K · filed 2017-03-14 |
| 2016-09-30 | $1.68 10-K · filed 2017-03-14 | -$0.10 derived: net income ÷ weighted average shares · filed 2017-11-09 | $1.79 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $0.12 10-K · filed 2017-03-14 | $0.11 10-Q · filed 2016-08-04 | ||
| 2016-03-31 | -$0.02 10-K · filed 2017-03-14 | |||
| 2015-12-31 | -$0.02 10-K · filed 2017-03-14 | -$0.05 10-K · filed 2017-03-14 | ||
| 2015-09-30 | -$0.02 10-K · filed 2017-03-14 | -$0.03 10-Q · filed 2016-11-04 | ||
| 2015-06-30 | -$0.04 10-K · filed 2017-03-14 | -$0.01 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | $0.02 10-K · filed 2017-03-14 | |||
| 2014-12-31 | -$0.04 10-K · filed 2016-03-11 | -$0.17 10-K · filed 2017-03-14 | ||
| 2014-09-30 | -$0.08 10-K · filed 2016-03-11 | |||
| 2014-06-30 | -$0.01 10-K · filed 2016-03-11 | |||
| 2014-03-31 | -$0.04 10-K · filed 2016-03-11 | |||
| 2013-12-31 | -$0.08 10-K · filed 2015-03-11 | |||
| 2013-09-30 | -$0.08 10-K · filed 2015-03-11 | |||
| 2013-06-30 | -$0.02 10-K · filed 2015-03-11 | |||
| 2013-03-31 | -$0.04 10-K · filed 2015-03-11 | |||
| 2012-12-31 | -$0.03 10-K · filed 2014-03-11 | |||
| 2012-09-30 | $0.00 10-K · filed 2014-03-11 | |||
| 2012-06-30 | -$0.02 10-K · filed 2014-03-11 | |||
| 2012-03-31 | -$0.06 10-K · filed 2014-03-11 | |||
| 2011-12-31 | $0.02 10-K · filed 2013-03-14 | |||
| 2011-09-30 | $0.00 10-K · filed 2013-03-14 | |||
| 2011-06-30 | -$0.05 10-K · filed 2013-03-14 | |||
| 2011-03-31 | -$0.04 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |